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ABSTRACT:

The Brucella abortus vaccine strain RB51 (SRB51) is being considered for use in the
management of brucellosis in wild bison (Bison bison) and elk (Cervus elaphus) populations in the
Greater Yellowstone Area (USA). Evaluation of the vaccine’s safety in non-target species was considered necessary prior to field use. Between June 1998 and December 1999, ground squirrels
(Spermophilus richardsonii, n 5 21), deer mice (Peromyscus maniculatus, n 5 14), prairie voles
(Microtus ochrogaster, n 5 21), and ravens (Corvus corax, n 5 13) were orally inoculated with
SRB51 or physiologic saline. Oral and rectal swabs and blood samples were collected for bacteriologic evaluation. Rodents were necropsied at 8 to 10 wk and 12 to 21 wk post inoculation (PI),
and ravens at 7 and 11 wk PI. Spleen, liver and reproductive tissues were collected for bacteriologic
and histopathologic evaluation. No differences in clinical signs, appetite, weight loss or gain, or
activity were observed between saline- and SRB51-inoculated animals in all four species. Oral and
rectal swabs from all species were negative throughout the study. In tissues obtained from SRB51inoculated animals, the organism was isolated from six of seven (86%) ground squirrels, one of six
(17%) deer mice, none of seven voles, and one of five (20%) ravens necropsied at 8, 8, 10, and 7
wk PI, respectively. Tissues from four of seven (57%) SRB51-inoculated ground squirrels were
culture positive for the organism 12 wk PI; SRB51 was not recovered from deer mice, voles, or
ravens necropsied 12, 21, or 11 wk, respectively, PI. SRB51 was not recovered from saline-inoculated ground squirrels, deer mice, or voles at any time but was recovered from one saline-inoculated
raven at necropsy, 7 wk PI, likely attributable to contact with SRB51-inoculated ravens in an
adjacent aviary room. Spleen was the primary tissue site of colonization in ground squirrels, followed
by the liver and reproductive organs. The results indicate oral exposure to SRB51 does not produce
morbibity or mortality in ravens, ground squirrels, deer mice, or prairie voles.
Key words: biosafety, Brucella abortus, brucellosis, deer mice, ground squirrels, non-targets,
ravens, RB51, voles.
INTRODUCTION

Brucellosis was detected in bison (Bison
bison) of Yellowstone National Park (YNP;
USA) in 1917, when serologic tests revealed Brucella spp. antibodies in two bison cows that had recently aborted (Mohler, 1917). In elk (Cervus elaphus) populations in YNP, brucellosis was detected as
early as 1930 (Murie, 1951). Infected bison and elk that roam outside of YNP have
the potential to transmit the disease to
brucellosis-free cattle herds in the surrounding Greater Yellowstone Area (GYA).
Because of the brucellosis-free status in

the states of Idaho, Wyoming, and Montana, there is interest in developing and
implementing an effective disease control
program for Brucella abortus in bison and
elk in the GYA.
Management strategies considered for
the control and eradication of brucellosis
in the GYA include vaccination of wild bison and elk populations. Brucella abortus
strain RB51 (SRB51), a rough, mutant variant of B. abortus strain 2308 (Schurig et
al., 1991), is a vaccine candidate for use in
wildlife. Strain RB51 has been shown to
be efficacious in cattle (Cheville et al.,
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1993), and safe in bison (Elzer et al., 1998;
Olsen et al., 1999) and elk (Cook et al.,
2000; Kreeger et al., 2000). Studies of
SRB51 in elk have failed to demonstrate
efficacy (Cook, 1999; Kreeger et al., 2000;
J.J. Kreeger, unpubl. data); in limited studies, SRB51 has produced protection in bison (Olsen et al., 2000; S.C. Olsens unpubl. data).
There is concern about the introduction
of a live vaccine into the GYA and its potential impact on resident animal populations that include unique genetics and
threatened or endangered species. The
Greater Yellowstone Interagency Brucellosis Committee (GYIBC; Boise, Idaho,
USA) a state and federal interagency committee established to facilitate the development and implementation of brucellosis
management plans for elk and bison in the
GYA, has identified several non-target species in the GYA in which the safety of any
vaccine candidate should be evaluated.
These species include representative ungulates, carnivores, rodents, and birds. In
nature, they would likely be exposed to the
organism via contact with SRB51-contaminated material or scavenging on an infected carcass. Several studies evaluating
the safety of SRB51 in non-target ungulates and carnivores have been completed
(T. J. Kreeger, pers. comm.). Additionally,
a study evaluating the safety of SRB51 in
deer mice (Peromyscus maniculatus) has
been reported (Cook et al., 2001). The
purpose of this study was to evaluate the
safety of oral exposure of common ravens
(Corvus corax), deer mice, Richardson’s
ground squirrels (Spermophilus richardsonii), and prairie voles (Microtus ochrogaster) to SRB51. These species were selected from the list of representative nontargets developed by the GYIBC.
MATERIALS AND METHODS

Thirteen mature and immature ravens of either sex were captured at the Larimer County
Landfill Fort Collins, Colorado (USA; 408309N,
105869W) and housed in pairs in an outdoor
aviary at a Colorado Division of Wildlife facility
(Fort Collins, Colorado) from June 1998 until
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November 1998. Twenty-one mature ground
squirrels of either sex captured near Roundup
(Montana, USA; 468279N, 1088289W), 21 mature deer mice of either sex selected from a
breeding colony located at the National Wildlife Research Center (NWRC; Fort Collins,
Colorado, USA), and 21 mature prairie voles of
either sex, wild-caught near the NWRC were
maintained individually in the Animal Research
Building (NWRC, Fort Collins, Colorado) from
July 1998 until September 1998, October 1998
until December 1998, and July 1999 until December 1999, respectively. Ravens were exposed to natural lighting and temperature conditions, and the rodent environment was temperature and light controlled (22 C, 12 hr light12 hr darkness cycle). Ravens, ground squirrels,
deer mice, and voles were randomly divided
into SRB51-inoculated (n 5 9, n 5 14, n 5 14,
n 5 14) and control (n 5 4, n 5 7, n 5 7, n 5
7) groups respectively. A commercially available SRB51 vaccine (Colorado Serum Company, Denver, Colorado) was rehydrated according to manufacturer’s instructions and diluted
in physiologic saline. SRB51-inoculated deer
mice and voles orally received SRB51 in a 1 ml
volume, whereas SRB51-inoculated ravens and
ground squirrels orally received SRB51 in a
0.25 ml volume. Control animals were given
the same oral volume of physiologic saline. After incubation at 37 C with 5% CO2 for 72 hr,
vaccine viability was determined by standard
plate counts on tryptose agar containing 5% bovine serum.
All animals were observed daily. Oral and
rectal swabs were collected from all ravens,
ground squirrels, and deer mice prior to inoculation and weekly throughout the study. In
voles, swabs were collected 1, 2, 4, 7 and 14
days PI and every 2 wk thereafter. In rodents,
fecal swabs were usually accompanied by one
or two fecal pellets expelled during the swabbing process. Collected swabs were stored at
269 C prior to bacteriologic evaluation. Based
on previous rodent studies (Stevens et al.,
1996), control and SRB51-inoculated deer
mice and ground squirrels were randomly selected to be euthanized for necropsy at 8 and
12 wk PI; ravens were necropsied at 7 and 11
wk PI and voles were necropsied at 10 and 21
wk PI. At necropsy, tissues were evaluated for
gross lesions, and spleen, liver, and reproductive tract (testes, accessory sex glands, uterine
horns and uterus) were collected for bacteriologic and histologic evaluation. Additionally,
samples of kidney, heart, and lung were collected for histologic evaluation. Histologic
specimens were placed in 10% neutral buffered
formalin whereas bacteriologic samples were
stored at 269 C until processing. Specimens

534

JOURNAL OF WILDLIFE DISEASES, VOL. 37, NO. 3, JULY 2001

were sent to the National Animal Disease Center (Ames, Iowa, USA) for bacteriologic evaluation and to the National Veterinary Services
Laboratories (Ames, Iowa) for histologic processing.
For bacteriologic evaluation, tissues were
weighted, minced using a tissue grinder, serially
diluted in saline, and placed on a selective medium for SRB51 (Hornsby et al., 2000). Antibiotics in the BR132 selective medium minimize growth of contaminants without inhibiting
the growth of SRB51, and thereby enhance the
ability to detect small numbers of SRB51 within samples. Oral and rectal swabs were directly
plated onto BR132 media. After incubation of
plates at 37 C with 5% CO for 72 hr, bacterial
cell counts were made from each dilution by
standard plate counts. Brucella spp. isolates
were identified as strain RB51 based on colony
morphology, growth characteristics (Alton et
al., 1988), rifampin resistance (Schurig et al.,
1991), and a Brucella spp. specific polymerase
chain reaction procedure based on that of
Bricker and Halling (1995). Briefly, the reaction mixture consisted of heat-killed cells, 0.2
mM nucleotide mix (Bochringer Mannheim,
Mannheim, Germany), 1 3 PCR Buffer II
(Perkin Elmer, Branchburg, New Jersey,
USA), 2.5 U/ml DNA polymerase (Amplitaq
Gold, Perkin Elmer, Branchburg, new Jersey),
and 1.5 mM MgCl combined with 20 pm per
reaction of specific primers for B. abortus
omp2A as selected from analysis of its sequence (Ficht et al., 1989) (upstream primer
GCAACGGTGTTCTTCCACTC and downstream primer GTATCAGGCTACGCAGAAGG). The samples, including positive and negative controls, were cycled (30 sec 95C, 30 sec
44C, 1 min 72C) 30 times in a thermocycler
(MJ Research Inc., Watertown, Massachusetts,
USA). Products (5 to 8:1 from each reaction
mixture) were separated by electrophoresis on
a 1.5% agarose gel and analyzed after staining
with ethidium bromide.
Formalin-fixed tissues were embedded in
paraffin, sectioned at a thickness of 5 mm, and
stained with hematoxylin and eosin for light microscopic examination. Spleens and reproductive tracts from deer mice and voles were not
collected for histopathology. Assessment of
morbidity was based on results of visual and
physical examination, including weight gain/
loss, evaluation of ocular and nasal secretions,
lethargy, fecal characteristics, feed intake, and
coat/feather appearance.
RESULTS

Standard plate counts indicated that
SRB51-inoculated ravens, ground squir-

rels, deer mice, and voles received 1.5 3
108, 7.8 3 107, 4.5 3 107, and 1.6 3 109
colony forming units (CFU) of SRB51, respectively.
Two ravens died during the study. The
first died during the acclimation period
prior to vaccination; the second raven died
2 wk post-vaccination after exhibiting respiratory distress of several days duration.
The cause of the first raven’s death was not
apparent. Lesions in the second raven indicated mycotic pneumonia and serositis.
One SRB51-inoculated mouse died immediately after inoculation and one control mouse died at 4 days PI. Deaths were
attributed to handling and probable aspiration of the inoculum. One control vole
died at 7 wk PI; the cause of death was
undetermined.
Bacteriologic cultures of oral and rectal
swabs from all species were negative for
recovery of SRB51. All tissues collected
from voles at necropsy 10 or 21 wk PI
were negative for brucellae. SRB51 was
isolated from tissues collected at necropsy
from one deer mouse, and ten ground
squirrels. Two ravens, including one in the
control group, were also culture-positive
for SRB51 (Table 1, 2). Colony counts varied from 1.0 colony forming units (CFU)/
g of tissue cultured to 8.0 3 104 CFU/g.
Tissues evaluated from remaining test animals were culture-negative for SRB51.
Gross lesions consisted of splenomegaly
and petechiation of the liver and testes in
one SRB51-inoculated ground squirrel
(CH23). Microscopic examination of tissue
sections from ravens, deer mice, and voles
revealed no difference between SRB51-inoculated and control animals. Livers of six
of the 10 culture-positive ground squirrels
contained small to moderate focal granulomas randomly located in the hepatic parenchyma. The granulomas consisted of
small and large mononuclear cells and rare
multinucleated cells. The granulomas were
often accompanied by focal necrosis and/
or increased periportal lymphoplasmacytic
infiltrates. One SRB51-inoculated vole
necropsied at 10 wk had a disseminated
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TABLE 1. Burella abortus SRB51 culture results (colony forming units (CFU)/g tissue cultured) on tissues
from culture-positive ravens, deer mice and ground squirrels.

Species

Animal IDa

Necropsy
(Wk PI)

Liver

Spleen

Reproductive
tract

Common raven
Common raven
Deer mouse
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel

803-T
805-C
BZ 13-T
CH 12-T
CH 13-T
CH 15-T
CH 17-T
CH 18-T
CH 22-T
CH 23-T
CH 25-T
CH 28-T
CH 29-T

7
7
8
8
8
8
8
8
8
12
12
12
12

2b
2
11
2
2
1
11
2
2
111
1
2
11

2
111
11
11
1
111
1111
1111
1
1111
1111
111
1111

1
2
1
2
2
2
1
2
2
1
2
2
2

a
b

T 5 SRB51-inoculated; C 5 Saline inoculated.
2 5 culture-negative for SRB51; 1 5 ,100 colony forming units (CFU)/g; 11 5 100–999 CFU/g; 111 5 1000-10,000
CFU/g; 1111 5 . 10,000 CFU/g.

histiocytic pneumonia and lymphoplasmacytic myocarditis of undetermined origin.
No lesions were noted in tissues from other animals.
No differences in clinical signs, appetite,
weight grain or loss, or activity were observed between control and SRB51-inoculated animals in all four species.
DISCUSSION

The negative culture results of the oral
and rectal swabs indicate a lack of persistent shedding of the SRB51 organism by
TABLE 2. Brucella abortus SRB51 culture-positive
animals per total number animals in group necropsied.

Species

Common raven
Deer mouse
Ground squirrel
Prairie vole
a

First
groupa
controls

First
group
vaccinates

Second
groupb
controls

Second
group
vaccinates

1/2
0/3
0/4
0/3

1/5
1/6
6/7
0/7

0/2
0/3
0/3
0/3

0/5
0/7
4/7
0/7

First group was necropsied at 7 wk PI (common ravens), 8
week PI (deer mice and ground squirrels) and 10 wk PI
(prairie voles).
b Second group was necropsied at 11 wk PI (common ravens), 12 wk PI (deer mice and ground squirrels), and 21
week PI (prairie voles).

any of the species tested. The SRB51 organism may have been shed by ravens,
ground squirrels, and deer mice during the
first few days PI and was therefore not detected as the first PI swabs were collected
at one wk PI. Surprisingly, the modified
collection protocol that was designed to
detect early shedding in the voles did not
result in positive cultures. The limited sensitivity of direct plating of fecal swabs may
not have allowed the detection of fecal
shedding of low numbers of SRB51 organisms.
The cause of SRB51 infection in the
control raven is undetermined. The organism may have been transferred to the bird
via direct contact as the infected control
raven was in an aviary room adjacent to
the SRB51-inoculated ravens; a small area
of the separating wall consisted of woven
wire. Alternatively, the organism could
have been transferred via contaminated
clothing, feed bowls, or capture nets and
drapes, or conceivably by wild deer mice
which frequented the outdoor aviary.
Tissue colonization of SRB51 appears to
persist in ground squirrels for a greater period of time than in the ravens, deer mice,
and voles. However, the SRB51 organism
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did not produce any clinical signs of illness
in any of the species studied. Clearance of
SRB51 by 12 wk in the deer mice and by
10 wk in the voles is consistent with results
from previous studies in mice. In one
study, BALB/c mice infected with 5 3 107
CFU of SRB51 intraperitoneally (IP)
cleared the infection between 30 and 60
days PI, whereas those infected with 1 3
104 CFU of virulent B. abortus strain 2308
harbored the bacteria through 60 days PI
(Palmer et al., 1996). In another study
BALB/c mice showed clearance of 9.2 3
106 CFU of SRB51 from spleens in ,6 wk
and persistance of 1.2 3 105 CFU of strain
2308 for .20 wk (Stevens et al., 1994). In
a third mouse study, SRB51 antigen persisted for 4 wk in parotid lymph nodes after oral inoculation with 5 3 108 CFU, but
the organism was not recovered from the
spleen between 2 and 12 wk PI. (Stevens
et al., 1996) In a recent deer mouse study,
orally inoculated mice receiving 1 3 108
CFU SRB51 cleared the infection by 6 wk
and mice receiving a similar inoculum IP
cleared the infection by 9 wk (Cook et al.,
2001) Granulomas similar to those noted
in the ground squirrel livers have been observed in B. abortus strain 19- inoculated
BALB/c mice (Enright et al., 1990) and
Brucella suis biovar 4-inoculated ground
squirrels (Citellus parryii) (Miller et al.,
1980).
In summary, oral exposure to SRB51 did
not produce observed morbidity or mortality in ravens, ground squirrels, deer
mice, or prairie voles. Neither fecal nor
oral shedding was detected. Ravens, deer
mice, and voles cleared the infection by 8
to 10 wk. However, SRB51 infection persisted in some ground squirrels for at least
12 wk. Further investigation to determine
the duration of SRB51 infection in ground
squirrels is merited.
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